Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Xuzi Cai"'
Autor:
Rui, Sun, Wen, Ma, Mingjian, Ling, Chenhong, Tang, Min, Zhong, Jingyue, Dai, Meiyan, Zhu, Xuzi, Cai, Guang, Li, Qing, Xu, Longguang, Tang, Zhiqiang, Yu, Zhenwei, Peng
Publikováno v:
Journal of Controlled Release. 350:525-537
To overcome drug resistance and improve precision theranostics for hepatocellular carcinoma (HCC), a nanoplatform with an "off/on" function for multimodality imaging (near-infrared-II (NIR-II) fluorescence imaging, magnetic resonance imaging (MRI), a
Autor:
Huijiao Fu, Xuzi Cai, Wen Ma, Chunhui Cui, Yuanyuan Yang, Gui Chen, Kangnan Wang, Zhiqiang Yu, Xuefeng Wang
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-13 (2021)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
Developing novel photosensitizers for deep tissue imaging and efficient photodynamic therapy (PDT) remains a challenge because of the poor water solubility, low reactive oxygen species (ROS) generation efficiency, serve dark cytotoxicity, and weak ab
Autor:
Xuzi Cai, Si Shi, Gui Chen, Min Zhong, Yuanyuan Yang, Ziyi Mai, Yang Tian, Jinxiu Tan, Lijuan He, Chunhui Cui, Zhiqiang Yu, Xuefeng Wang
Publikováno v:
Acta biomaterialia.
Platinum-based chemotherapy is a first-line therapeutic regimen against ovarian cancer (OC); however, the therapeutic potential is always reduced by glutamine metabolism. Herein, a valid strategy of inhibiting glutamine metabolism was proposed to cau
Autor:
Zhandong Yang, Huijiao Fu, Huihui Su, Xuzi Cai, Yan Wang, Yanjun Hong, Jing Hu, Zhiyong Xie, Xuefeng Wang
Publikováno v:
Frontiers in microbiology. 13
ObjectiveThe purpose of this study was to investigate the specific alterations in gut microbiome and serum metabolome and their interactions in patients with polycystic ovary syndrome (PCOS).MethodsThe stool samples from 32 PCOS patients and 18 healt
Autor:
Guang Li, Mingjian Ling, Kunyi Yu, Wei Yang, Qiwen Liu, Lijuan He, Xuzi Cai, Min Zhong, Ziyi Mai, Rui Sun, Yuanling Xiao, Zhiqiang Yu, Xuefeng Wang
Publikováno v:
Journal of nanobiotechnology. 20(1)
Ovarian cancer is a highly fatal gynecologic malignancy worldwide. Chemotherapy remains the primary modality both for primary and maintenance treatments of ovarian cancer. However, the progress in developing chemotherapeutic agents for ovarian cancer
Autor:
Zhandong Yang, Xuzi Cai, Xiaoxia Xu, Zengmei Xu, Simin Ye, Yan Wang, Yanjun Hong, Baochun Shen, Qiongfeng Liao, Zhiyong Xie, Xuefeng Wang
Publikováno v:
Analytical Biochemistry. 647:114665
Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder. Nevertheless, its accurate mechanisms remain unclear. Metabolomics is a powerful technique to identify small molecules that could be used to discover pathogenesis and ther
Background: Apoptosis of ovarian granulosa cells (GCs) is a sign of follicular atresia. This study aimed to explore the role and mechanism of signal peptide, CUB domain, epidermal growth factor-like protein1 (SCUBE1) in protecting GCs from apoptosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fa6ddc53d38e1e03cf7935fda91c1a4
https://doi.org/10.21203/rs.3.rs-285634/v1
https://doi.org/10.21203/rs.3.rs-285634/v1
Autor:
Yibing, Li, Yilin, Zhu, Xuzi, Cai, Jimin, Guo, Cuiping, Yao, Qiling, Pan, Xuefeng, Wang, Kang-Nan, Wang
Publikováno v:
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy. 251
The unbalanced metabolism of sulfur dioxide can cause various diseases, such as neurological disorders and lung cancer. Until now, some researches revealed that the normal function of lysosomes would be disrupted by its abnormal viscosity. As a signa
Publikováno v:
Journal of Ovarian Research, Vol 13, Iss 1, Pp 1-10 (2020)
Journal of Ovarian Research
Journal of Ovarian Research
Background Genetic causes of premature ovarian insufficiency (POI) account for approximately 20 ~ 25% of patients. So far, only a few genes have been identified. Results Here, we first identified the c.1840C > A on G-protein signaling modulator 1 (GP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::480c5dcb694e508162328502e9eb5705
https://doi.org/10.21203/rs.3.rs-18442/v2
https://doi.org/10.21203/rs.3.rs-18442/v2
Whole-exome sequencing identifies GPSM1 as a susceptibility gene for premature ovarian insufficiency
Background Genetic causes of premature ovarian insufficiency (POI) account for approximately 20~25% of patients. So far, only a few genes have been identified. Results Here, we first identified the c.1840C>A on G-protein signaling modulator 1 (GPSM1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cda20c72161c5e767d8b1624fbbee972
https://doi.org/10.21203/rs.3.rs-18442/v1
https://doi.org/10.21203/rs.3.rs-18442/v1